SPDR S&P Biotech ETF Rating $82.93 -0.08 (-0.10%) As of 06/30/2025 04:10 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartDividendHeadlinesHoldingsOwnershipRatingsShort InterestBuy This Stock SPDR S&P Biotech ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.XBI Aggregate RatingModerate Buy 2.73Holdings in XBI have an aggregate rating of Moderate Buy based on 757 analyst ratings issued in the past year covering 50 companies (78.1% of the portfolio).XBI Aggregate Price Target$82.93High Prediction$82.93Average Prediction$82.93Low Prediction$82.93Holdings in XBI have an aggregate price target of $82.93 and a range of $82.93 to $82.93 covering 50 companies (78.1% of the portfolio).XBI Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy14 Buy rating(s)Moderate Buy28 Moderate Buy rating(s)Hold8 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by SPDR S&P Biotech ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 50 XBI Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings3.53%INSMInsmed$100.64+1.2%4.0849 of 5 stars3.00$106.80 6.1%17Positive News3.25%ALNYAlnylam Pharmaceuticals$326.09+1.0%4.2605 of 5 stars2.79$340.00 4.3%24Positive NewsAnalyst Forecast3.03%NTRANatera$168.94+0.6%1.3359 of 5 stars3.00$184.63 9.3%15Positive News3.00%BPMCBlueprint Medicines$128.18+0.1%1.7234 of 5 stars2.27$128.06 -0.1%22Positive News2.95%NBIXNeurocrine Biosciences$125.69+0.2%4.9106 of 5 stars2.86$162.00 28.9%22Positive News2.91%EXASExact Sciences$53.14-1.0%4.8676 of 5 stars2.95$70.40 32.5%222.57%INCYIncyte$68.10-0.4%4.3355 of 5 stars2.22$74.53 9.4%182.42%GILDGilead Sciences$110.87+0.2%4.8176 of 5 stars2.78$110.55 -0.3%27Positive News2.41%UTHRUnited Therapeutics$287.35+1.1%4.9933 of 5 stars2.69$386.15 34.4%13Analyst Forecast2.36%AMGNAmgen$279.21+0.8%4.6863 of 5 stars2.35$307.82 10.2%23Trending News2.31%BIIBBiogen$125.59-0.4%4.9535 of 5 stars2.38$188.48 50.1%322.27%VRTXVertex Pharmaceuticals$445.20+0.9%4.6891 of 5 stars2.54$511.62 14.9%28Positive News2.23%ABBVAbbVie$185.80+1.9%4.935 of 5 stars2.81$211.29 13.7%27Trending News2.19%EXELExelixis$44.08+0.9%4.6494 of 5 stars2.52$43.56 -1.2%21Positive NewsAnalyst ForecastGap Up2.01%MDGLMadrigal Pharmaceuticals$302.64+0.6%3.9216 of 5 stars2.89$420.63 39.0%91.99%BBIOBridgeBio Pharma$43.18-3.7%4.6848 of 5 stars2.93$58.85 36.3%14Analyst ForecastInsider TradeHigh Trading Volume1.88%MRNAModerna$27.59+1.6%4.5255 of 5 stars2.04$46.61 68.9%23Trending NewsGap Up1.88%REGNRegeneron Pharmaceuticals$525.00+0.8%4.9306 of 5 stars2.80$813.57 55.0%25Analyst Downgrade1.70%BMRNBioMarin Pharmaceutical$54.97-0.4%4.9475 of 5 stars2.74$93.45 70.0%23Positive News1.55%IONSIonis Pharmaceuticals$39.51-0.7%4.1104 of 5 stars2.72$57.88 46.5%181.54%TGTXTG Therapeutics$35.99-2.0%3.8554 of 5 stars2.80$40.80 13.4%5Positive News1.53%RVMDRevolution Medicines$36.79-0.3%4.4555 of 5 stars3.00$67.58 83.7%12Gap Up1.52%CRSPCRISPR Therapeutics$48.64+2.4%2.9283 of 5 stars2.53$71.75 47.5%17High Trading Volume1.38%HALOHalozyme Therapeutics$52.02-0.4%4.8327 of 5 stars2.17$61.90 19.0%12Analyst RevisionHigh Trading Volume1.34%ROIVRoivant Sciences$11.27-1.1%2.055 of 5 stars3.00$17.50 55.3%41.23%SWTXSpringWorks Therapeutics$46.99+0.0%1.537 of 5 stars2.13$52.57 11.9%8Positive News1.13%CYTKCytokinetics$33.04-0.4%4.2467 of 5 stars2.93$70.92 114.7%15Positive News1.13%VKTXViking Therapeutics$26.50-0.1%4.12 of 5 stars3.00$87.15 228.9%14Gap Up1.11%SMMTSummit Therapeutics$21.28+3.3%2.6265 of 5 stars2.77$35.09 64.9%13Analyst Upgrade1.07%ACADACADIA Pharmaceuticals$21.57-2.5%4.5922 of 5 stars2.71$27.88 29.2%171.03%ALKSAlkermes$28.61-0.7%4.9046 of 5 stars2.83$40.00 39.8%12Positive News1.02%PCVXVaxcyte$32.51-0.2%1.886 of 5 stars3.10$136.50 319.9%10Positive News1.00%RNAAvidity Biosciences$28.40-2.2%2.3492 of 5 stars3.06$65.59 130.9%170.95%AKROAkero Therapeutics$53.36-5.0%3.5265 of 5 stars3.00$82.50 54.6%60.93%ADMAADMA Biologics$18.21+0.3%4.0366 of 5 stars3.33$27.67 51.9%30.90%SRRKScholar Rock$35.42-1.1%3.6519 of 5 stars3.14$42.67 20.5%70.90%NUVLNuvalent$76.30-4.2%2.8208 of 5 stars2.92$119.60 56.7%120.87%ACLXArcellx$65.85+0.8%2.8628 of 5 stars3.07$111.23 68.9%15Positive News0.87%SLNOSoleno Therapeutics$83.78+0.6%4.6665 of 5 stars3.09$107.10 27.8%110.84%RYTMRhythm Pharmaceuticals$63.19+0.7%3.8723 of 5 stars3.00$77.31 22.3%130.81%TWSTTwist Bioscience$36.79+2.4%4.4194 of 5 stars2.70$50.40 37.0%10Positive News0.78%RAREUltragenyx Pharmaceutical$36.36-0.4%3.9129 of 5 stars2.93$87.00 139.3%140.76%AGIOAgios Pharmaceuticals$33.26-0.6%4.016 of 5 stars2.71$58.60 76.2%70.75%KRYSKrystal Biotech$137.46-1.0%4.5932 of 5 stars3.00$211.13 53.6%90.75%APLSApellis Pharmaceuticals$17.31-0.7%4.4958 of 5 stars2.62$40.05 131.4%21Positive News0.73%CRNXCrinetics Pharmaceuticals$28.76-4.0%3.5393 of 5 stars2.91$74.56 159.2%110.71%RXRXRecursion Pharmaceuticals$5.06+0.6%2.0405 of 5 stars2.33$7.00 38.3%60.70%ARWRArrowhead Pharmaceuticals$15.80-1.7%3.75 of 5 stars2.75$43.71 176.7%80.69%VCYTVeracyte$27.03-1.3%3.4572 of 5 stars2.70$40.90 51.3%10Analyst Downgrade0.68%PTCTPTC Therapeutics$48.84-2.0%4.3309 of 5 stars2.67$65.00 33.1%15Gap Down This page (NYSEARCA:XBI) was last updated on 7/1/2025 by MarketBeat.com Staff From Our PartnersThis Crypto Is Set to Explode in JanuaryFree summit: How to profit from the Coinbase-Deribit deal Our hedge fund experts know exactly what this mea...Crypto 101 Media | SponsoredTrump set to Boost Social Security Checks by 400%?If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredHow to Collect Up To $5,917/mo From Trump’s Made In USA BoomHow to Collect Up To $5,917/mo From Trump's Made In USA Boom Thanks to President Trump's America-First poli...Investors Alley | SponsoredGold prediction: $5,000/oz. or higher is comingThe perfect gold play right now? (currently under $10) Everything in the news now lines up perfectly for an...Stansberry Research | SponsoredNvidia’s Huang: AI is going to need 100x more power12Nvidia CEO Jensen Huang didn't mince words. After Nvidia's latest earnings call, Huang said AI now requires...Weiss Ratings | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SPDR S&P Biotech ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share SPDR S&P Biotech ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
